Morning brief · Monday, 20 July 2026
Biotech's new moat: from science to reliable, large scale manufacturing
Week ahead
This week, the earnings season hits its stride with reports anticipated from heavyweights like Infosys, UltraTech Cement, Bajaj Auto, and Nestlé India, offering a fresh look into corporate health. Investors will also watch for global cues as the European Central Bank holds a policy meeting, while escalating tensions between the US and Iran could introduce volatility in crude oil prices. Closer to home, the commerce ministry is set to release a revamped Index of Core Industries on Monday, providing a new gauge of economic activity.
From the investor's mind
One post worth your time, explained

@unseenvalue · on X
Sajal Kapoor highlights a significant shift in the biotechnology landscape, noting its evolution into an engineering discipline. As medicine transitions from an analog to a digital paradigm, the critical differentiator is no longer solely scientific discovery. Instead, the capacity to precisely, consistently, and reliably manufacture complex biological products at scale has become the scarce and valuable asset. This emphasizes a move towards operational excellence and robust production capabilities within the biotech sector.
Yesterday's big moves
Home First Finance Company India LimitedNewly DisclosedQuarterly
₹1,242Past year ▼ 10%M.cap ₹13,181 Cr
Sundaram Mutual Fund
Home First Finance Company India LimitedNewly DisclosedQuarterly
₹1,242Past year ▼ 10%M.cap ₹13,181 Cr
Mirae Asset Mutual Fund
Home First Finance Company India LimitedNewly DisclosedQuarterly
₹1,242Past year ▼ 10%M.cap ₹13,181 Cr
Kotak Mutual Fund
DHP India LtdIncreasedSAST
M.cap ₹155 Cr
Counter Cyclical
V-Guard Industries LimitedDecreasedSAST
₹300Past year ▼ 25%M.cap ₹13,297 Cr
SBI Mutual Fund
“The investor's chief problem, and even his worst enemy, is likely to be himself.”
Benjamin Graham
See what the smart money is buying, before the news does
Follow Kacholia, Damani, Rekha Jhunjhunwala and 300+ top investors. Every new position, bulk deal and insider trade, the moment it happens.
